Cambrium
11 known investors
Find your way into Cambrium
877 people in our graph share verified history with the Cambrium team — schools, employers, funds. One of them is your warm intro.
Cambrium designs novel molecules and materials by combining AI with bioscience disciplines such as molecular biology, protein engineering, and material science. It develops engineered proteins and materials for industrial and commercial applications.
Also known as Cambrium GmbH
Founders & leadership
Investors · 11
.jpeg){kind=logo}
Also in the syndicate · 2
Funding
SEC filings, press & company announcements- Undisclosed amountseed funding roundNov 2023 · 2 sources
Essential Capital (lead), HOF Capital, Merantix, SNR, Valor Equity Partners
Source ↗ - Undisclosed amountSeed FundingOct 2023 · 2 sources
Essential Capital (lead), HOF Capital, SNR, Valor Equity Partners
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Company profile
researched Aug 2026Cambrium (Cambrium GmbH) is a Germany-based materials company that develops high-performance materials through a platform spanning three molecular systems: enzymes, polymers and peptides. The company positions its work around designing and producing molecules at scale, combining computational prediction of molecular behaviour with biological production systems to obtain performance characteristics it describes as inaccessible to conventional chemistry.
The company markets named material outputs including RevaBond, midsole foam, microcellular foam and protective coatings, and states that it works with partner companies on specific performance challenges rather than offering only off-the-shelf products.
Business model
Cambrium describes partnering with companies that want to address material performance challenges, developing materials for them on its platform; the site invites prospective partners to get in touch.
▸Full profile — market position, technology, go-to-market, geography
Market position
Positions itself as building next-generation materials that outperform incumbent alternatives, applying one adaptable platform across multiple industrial sectors.
Technology
The platform designs and produces enzymes, polymers and peptides at scale. Cambrium describes using molecular intelligence to predict how molecules will behave before they are made, and living (biological) systems to produce them, targeting performance characteristics beyond those of traditional chemistry.
Go-to-market
Partnership-led: Cambrium works directly with companies on their material performance requirements, with contact and partnership calls to action on its website.
Companies in sectors where material performance is central, including apparel and footwear, personal care, mobility (automotive), home care, textiles, cosmetics and construction.
Geography
Headquartered in Germany; the company operates as Cambrium GmbH.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
In the news
▸Research sources · 1
primary sources listed
- Cambriumcambrium.bio · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Cambrium do?
- Cambrium is a German materials company using a molecular design platform to engineer enzymes, polymers and peptides.
- Who founded Cambrium?
- Cambrium was founded by Mitchell Duffy, Charlie Cotton, PhD.
- Who are Cambrium's investors?
- Cambrium's investors include DG Daiwa Ventures, Earth Venture Capital, Gradient Ventures, Juniper, SBI Ventures Europe GmbH, Transpose Platform Management, HOF Capital, Merantix Capital and 1 more.